Literature DB >> 16112774

Radiosensitizing effect of zoledronic acid in small cell lung cancer.

A Ugur Ural, Ferit Avcu.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16112774     DOI: 10.1016/j.lungcan.2005.06.003

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


× No keyword cloud information.
  7 in total

1.  Zoledronic acid augments the radiosensitivity of cancer cells through perturbing S- and M-phase cyclins and p21CIP1 expression.

Authors:  Chi Du; Yuyi Wang; Haijun Li; Yi Huang; Ou Jiang; Yanjie You; Feng Luo
Journal:  Oncol Lett       Date:  2017-08-03       Impact factor: 2.967

Review 2.  Bisphosphonate treatment and radiotherapy in metastatic breast cancer.

Authors:  A Ugur Ural; Ferit Avcu; Yusuf Baran
Journal:  Med Oncol       Date:  2008-01-17       Impact factor: 3.064

3.  Zoledronic acid and radiation: toxicity, synergy or radiosensitization?

Authors:  M Alcaraz; A Olivares; D Armero; M Alcaraz-Saura; D Achel
Journal:  Clin Transl Oncol       Date:  2012-07-24       Impact factor: 3.405

4.  The enhancement of radiosensitivity in human esophageal squamous cell carcinoma cells by zoledronic acid and its potential mechanism.

Authors:  Yanjie You; Jianfeng Liu; Zhizhong Wang; Yuan Zhang; Yonggang Ran; Xu Guo; Huimin Liu; Haibo Wang
Journal:  Cytotechnology       Date:  2013-01-19       Impact factor: 2.058

5.  Toxicity of a dental adhesive compared with ionizing radiation and zoledronic acid.

Authors:  Miguel Alcaraz; Amparo Olivares; Daniel-Giyngiri Achel; Emilio García-Cruz; Adriana Fondevilla-Soler; Manuel Canteras-Jordana
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2015-07-01

6.  Zoledronic acid is an effective radiosensitizer in the treatment of osteosarcoma.

Authors:  Eun Ho Kim; Mi-Sook Kim; Kyung-Hee Lee; Jae-Soo Koh; Won-Gyun Jung; Chang-Bae Kong
Journal:  Oncotarget       Date:  2016-10-25

7.  The effects of bisphosphonate and radiation therapy in bone-metastatic lung adenocarcinoma: the impact of KRAS mutation.

Authors:  Peter Radeczky; Zsolt Megyesfalvi; Viktoria Laszlo; Janos Fillinger; Judit Moldvay; Erzsebet Raso; Erzsebet Schlegl; Tamas Barbai; Jozsef Timar; Ferenc Renyi-Vamos; Balazs Dome; Balazs Hegedus
Journal:  Transl Lung Cancer Res       Date:  2021-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.